• M.D. – Catholic University of Rome, Italy
• Ph.D. – Catholic University of Rome, Italy
• Clinical Residency and Board, Internal Medicine, Catholic University of Rome, Italy
• Postdoctoral Fellowship, Psychiatry and Human Behavior, Brown University, Providence, RI, USA

• 05/23 – present   Clinical Director, NIDA IRP
• 11/20 – present    Deputy Scientific Director, NIDA IRP
• 07/19 – present    Chief, Translational Addiction Medicine Branch, NIDA IRP
• 12/18 – present    Senior Investigator (Clinical; Tenured); joint NIDA IRP and NIAAA DICBR
• 06/12 – present    Chief, Clinical Psychoneuroendocrinology and Neuropsychopharmacology (CPN) Section; joint NIDA IRP and NIAAA DICBR, NIH (primary appointment with NIAAA until 2018, then with NIDA)
• 01/21 – present    Director, Translational Analytical Core (TAC), Office of the Scientific Director, NIDA IRP
• 07/14 – present    Senior Attending Medical Staff, NIH
• 02/17 – present    Professor (Adjunct), Department of Behavioral and Social Sciences, School of Public Health, Brown University, Providence, RI
• 12/19 – present    Professor (Adjunct), Division of Addiction Medicine, Department of Medicine, School of Medicine, Johns Hopkins University, Baltimore, MD
• 01/20 – present    Professor (Adjunct), Department of Neuroscience, School of Medicine, Georgetown University Medical Center, Washington, DC
• 01/22 – 05/23      Acting Clinical Director, NIDA IRP
• 01/16 – 05/23       Associate Director for Clinical Research, Medication Development Program (MDP), NIDA IRP
• 06/12 – 12/18       Clinical Investigator (Tenure-Track); joint NIAAA DICBR and NIDA IRP, NIH
• 07/13 – 01/17       Associate Professor (Adjunct), Department of Behavioral and Social Sciences, School of Public Health, Brown University, Providence, RI
• 04/10 – 06/12       Assistant Professor (Research), Department of Behavioral and Social Sciences (formerly Community Health), Warren Alpert Medical School and Public Health Program, Brown University, Providence, RI

• 2008 - Nordmann Award, European Society for Biomedical Research on Alcoholism
• 2016 - Early Career Investigator Award, Research Society on Alcoholism
• 2018 - Eva King Killam Research Award, American College of Neuropsychopharmacology
• 2020 - Jacob P. Waletzky Award, Society for Neuroscience
• 2022 - Elected Fellow, American College of Neuropsychopharmacology
• 2023 - Ward & Ryan Donovan Lectureship Award, American College of Medical Toxicology

• M.B.A., Norwich University
• B.A., James Madison University

• NIDA Budget Officer & Chief, Financial Management Branch
• NIMHD Budget Officer & Chief, Financial Management Branch
• Deputy Comptroller, 80^th Training Command (TASS), U.S. Army Reserve
• Active Duty Officer, U.S. Army

• Appointed to the Senior Executive Service in 2023
• Recipient of multiple awards at the Institute and NIH level

• Ph.D., Case Western Reserve University
• M.S., University of Wisconsin, Madison
• B.S., University of Wisconsin, Madison

• Senior Scientist and Director of the Office of Functional Genomics, Oak Ridge National Laboratory
• Professor and Vice Chair for Research, Dept. of Pediatrics, Case Western Reserve University
• Senior Director, Parke-Davis Laboratory for Molecular Genetics
• Chief Scientific Officer, Lynx Therapeutics
• President and CEO, The Jackson Laboratory

• Led the strategic planning and implementation efforts for NIEHS.
• Research laboratory discovered a number of important genes, including the first obesity gene, first gene associated with polycystic kidney disease, and gene associated with hearing loss

Ph.D., Biochemistry Queen's University

Chief Epigenetics and Stem Cell Biology Laboratory, NIEHS

2019 NIH Director's Award and NIH Distinguished Investigator

2022 NIH Director's Award

• M.D., Indiana University
  
• B.A., Boston University

• Conducts research focused on understanding the role of eicosanoids in pulmonary and cardiovascular function.
• Author of more than 375 peer-reviewed articles in leading biomedical journals as well as numerous reviews and book chapters.
• Directs a clinical/translational research program focused on the role of the environment in asthma pathogenesis.
• Elected to the American Society for Clinical Investigation (ASCI) and American Association of Physicians (AAP), and as a Fellow in the American Heart Association.
• Member of the editorial boards of several top scientific journals.

• B.S. University of Florida 
• Ph.D. Emory University

• Professor, NC State University 
• Associate Dean for Research, College of Sciences, NC State University

• Directs a research program on environmental impacts on brain development and behavior 
• 2007 NIEHS ONES Awardee 
• 2022 SOT Reproductive and Developmental Specialty Section Mid-Career Award

• A.B., Princeton University
• M.D., Harvard Medical School

• Directs research program focused on the role of sterols and mitochondria in immunity and disease
• Adjunct Professor of Medicine, Duke University School of Medicine
• Elected to the American Society for Clinical Investigation
• Deputy Editor, American Journal of Respiratory Cell and Molecular Biology
• Carol Basbaum Award, American Thoracic Society
• NIEHS Scientific Director’s Award for Outstanding Intramural Research
• Principal Investigator, Trans-NIH Metabolomics Consortium

• Postdoctoral Fellow, Biochemistry and biophysics, University of North Carolina 
• PhD, Pharmacology and Cellular Biophysics, University of Cincinnati 
• BA, Chemistry, Kenyon College

• Chief, Exposure, Response, and Technology Branch, NIEHS 
• Program Officer, Center for Risk and Integrated Sciences, NIEHS 
• Program Officer, Arrhythmia, Ischemia, and Sudden Cardiac Death Research Group, NHLBI

• Co-Chair, OSTP Joint Subcommittee on Environment, Innovation, and Public Health 
• Internationally recognized leader in the development and implementation of the exposome 
• Co-founder and inaugural chair of the NIH Systems Biology Interest Group

• M.S., Columbia University 
• B.S., Yale University

•  NIEHS, Chief of Administrative and Research Services, Division of Intramural Research

• Award-winning leader recognized by U.S. Department of Labor, U.S Department of Health and Human Services, U.S. Small Business Administration, and U.S. Conference of Mayors for administrative and operational management expertise in support of multiple federal agencies and academia. 
• Recognized proficiency in federal management including planning and executing operational budgets in excess of $850 million. 
• Proven skills and experience in human capital strategic planning and management including complex workforce planning involving the design and innovation of human resources strategies to meet organizational mission, strategic vision, and goals.

• Ph.D., Harvard University

• B.A., Swarthmore College

• Committed to question-driven, investigator-initiated basic research.
• Does research in the field of RNA biology that is focused on the initiation of translation, a major step in controlling how genes are expressed.
• Formerly a professor in the Department of Biophysics and Biophysical Chemistry at the Johns Hopkins University School of Medicine.

• Ph.D, The Weizmann Institute of Science, Israel
•  B.Sc, Tel Aviv University, Israel  

• Director, Division of Genetics & Molecular, Cellular, & Developmental Biology, NIGMS
• Director, Office of Policy and Communications, NCATS
• Science Policy Advisor to NIH Deputy Director for Extramural Research  

• Led an effort on the use of a wide variety of research organisms in basic biomedical research
•  Established a joint NSF/NIGMS program to support research on science and innovation policy in the biomedical sciences
•  Led the development of the first NCATS strategic plan
•  Chaired the AAAS S&T Policy Fellowships Advisory Committee
• Managed the Advisory Committee to the NIH Director Working Group on the biomedical research workforce

• Bachelor of Arts in History, University of MD, College Park

• Graduate of the HHS SES Candidate Development Program; the Asian American Government Executives Network SES Development Program; and the OPM Women’s Executive Leadership Program.
• Has served as the NIGMS EO since 2007 and prior to that was the Deputy EO since 2000. Recipient of the NIH Director's Award (2012 and 2013) and NIH Merit Award (1994, 2006, and 2011).
• Has led several NIH committees, including the Administrative Training Committee, CIVIL Advisory Committee, and ORS Advisory Committee.

• Ph.D.,Temple University

• Deputy Director, NIMH

• Co-investigator on the National Comorbidity Study – Adolescent Component, one of the most comprehensive studies gathering evidence on the prevalence and course of mental disorders in adolescents.
• As Chief of the Developmental Trajectories Branch of Mental Disorders Branch, led the reorienting of NIMH’s pediatric translational research portfolio towards an emphasis on brain and behavioral development, trajectories of mental illnesses, and early biological or behavioral markers of risk and intervention. Developed several research programs focused on depression, anxiety, bipolar disorder and chronic irritability in children and adolescents. 
• As Deputy Director of NIMH, played a pivotal role in defining the institute's research priorities, policies, and strategic initiatives. Contributed significantly to numerous key NIMH, NIH, and trans-agency efforts on youth mental health, COVID-19, maternal health, and suicide prevention, including several Suicide Prevention research efforts, the Adolescent Brain Cognitive Development Study (ABCD), Environmental Influences on Child Health Outcomes Study (ECHO), the All of Us research program, Task Force on Research Specific to Pregnant Women and Lactating Women, the NIH UNITE initiative, and several White House initiatives focused on transforming care for mental disorders.  

• B.A. Columbia University 
• Ph.D. Washington University

• Deputy Director, Division of Neuroscience and Basic Behavioral Science, NIMH

• Major role in managing a $350M portfolio of research grant awards; co-lead of the Common Fund GTEx project

• Ph.D., University of California, San Diego

• B.S., Stanford University

• Held faculty positions at Yale University School of Medicine and the Vollum Institute in Portland Oregon, and was a Howard Hughes Investigator at each of these institutions; and was the Thomas Detre Chair of Neurobiology and Distinguished Professor at the University of Pittsburgh School of Medicine.
• Member of the National Academy of Sciences, fellow of the American Association for the Advancement of Science.
• Recipient of several awards, including the George Herbert Hitchings Award for innovative methods in drug discovery from the Burroughs Wellcome Fund, a NARSAD Distinguished Investigator Award, and the Julius Axelrod Prize from the Society for Neuroscience; and has had 20 U.S. patents issued on technology from her laboratory.